Insider Trading: AcelRx Pharmaceuticals Inc (ACRX.O)
ACRX.O on Consolidated Issue listed on NASDAQ Global Market
7.58USD
24 May 2013
7.58USD
24 May 2013
Price Change (% chg)
$0.13 (+1.75%)
$0.13 (+1.75%)
Prev Close
$7.45
$7.45
Open
$7.50
$7.50
Day's High
$7.69
$7.69
Day's Low
$7.36
$7.36
Volume
60,572
60,572
Avg. Vol
353,676
353,676
52-wk High
$7.69
$7.69
52-wk Low
$2.27
$2.27
| WELCH JAMES H | Options Exercised: 0 | ||
| Trade Date: | Monday, 5 Sep 2011 | Price: | 3.32 |
| Title: | Chief Financial Officer | Shares Held: | 15,000 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 10,000 |
Institutional Holders
| % Shares Owned: | 78.58% |
| # of Holders: | 40 |
| Total Shares Held: | 29,259,666 |
| 3 Mo. Net Change: | -1,280,050 |
| # New Positions: | 12 |
| # Closed Positions: | 10 |
| # Increased Positions: | 24 |
| # Reduced Positions: | 16 |
| # Net Buyers: | 8 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Adrian Adams |
62 | 2013 | Independent Chairman of the Board |
Richard King |
48 | 2010 | President, Chief Executive Officer, Director |
James Welch |
55 | 2010 | Chief Financial Officer |
Pamela Palmer |
50 | 2005 | Chief Medical Officer, Director |
Badri Dasu |
49 | 2007 | Chief Engineering Officer |
Lawrence Hamel |
61 | 2006 | Chief Development Officer |
Mark Edwards |
55 | 2011 | Independent Director |
Stephen Hoffman |
58 | 2010 | Independent Director |
Guy Nohra |
52 | 2006 | Independent Director |
Howard Rosen |
54 | 2008 | Independent Director |
Mark Wan |
47 | 2006 | Independent Director |

